Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
104 rows where in_cev_map = 0, surface_class = "A2_pm_peripheral" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
tier 1
- Tier 1.5 · 104 ✖
surface_class 1
- A2_pm_peripheral · 104 ✖
in_cev_map 1
- - · 104 ✖
has_activation_state_pdb_pair 1
- 0 104
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q9Y4U1 | MMACHC | Cyanocobalamin reductase / alkylcobalamin dealkylase | Tier 1.5 | 0.644 | 1 | A2_pm_peripheral | 7 | 85.62 | 0 | 0 | 0 | 0 | 0 | Methylmalonic acidemia with homocystinuria, type cblC | 0.8478185420804271 | |||
| Q9Y215 | COLQ | Acetylcholinesterase collagenic tail peptide | Tier 1.5 | 0.629 | 1 | A2_pm_peripheral | 1 | 54.47 | 0 | 0 | 0 | 0 | 0 | Congenital myasthenic syndromes | 0.796199449860989 | |||
| Q68CZ1 | RPGRIP1L | Protein fantom | Tier 1.5 | 0.628 | 1 | A2_pm_peripheral | 1 | 70.06 | 0 | 0 | 0 | 0 | 0 | Joubert syndrome with hepatic defect | 0.7930231953177929 | |||
| P49459 | UBE2A | Ubiquitin-conjugating enzyme E2 A | Tier 1.5 | 0.626 | 1 | A2_pm_peripheral | 5 | 94.12 | 1 | 0 | 0 | 0 | 0 | syndromic X-linked intellectual disability Nascimento type | 0.7867796040270276 | |||
| P15104 | GLUL | Glutamine synthetase | Tier 1.5 | 0.622 | 1 | A2_pm_peripheral | 12 | 97.5 | 1 | 0 | 1 | 4 | 39533430, 30085248, 21282981 | 0 | congenital brain dysgenesis due to glutamine synthetase deficiency | 0.7733687702812198 | ||
| Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | Tier 1.5 | 0.619 | 1 | A2_pm_peripheral | 1 | 63.19 | 0 | 0 | 0 | 0 | 0 | Recurrent infection due to specific granule deficiency | 0.7619369036825959 | |||
| Q96CW9 | NTNG2 | Netrin-G2 | Tier 1.5 | 0.616 | 1 | A2_pm_peripheral | 3 | 84.5 | 0 | 0 | 0 | 0 | 0 | neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia | 0.7527757254195254 | |||
| P48788 | TNNI2 | Troponin I, fast skeletal muscle | Tier 1.5 | 0.613 | 1 | A2_pm_peripheral | 2 | 80.69 | 0 | 0 | 0 | 0 | 0 | distal arthrogryposis type 2B1 | 0.7424838485252128 | |||
| O14640 | DVL1 | Segment polarity protein dishevelled homolog DVL-1 | Tier 1.5 | 0.611 | 1 | A2_pm_peripheral | 3 | 59.84 | 0 | 0 | 1 | 1 | 37231925 | 0 | autosomal dominant Robinow syndrome | 0.7359277384599506 | ||
| Q6EMB2 | TTLL5 | Tubulin polyglutamylase TTLL5 | Tier 1.5 | 0.607 | 1 | A2_pm_peripheral | 1 | 61.41 | 0 | 0 | 0 | 0 | 0 | Cone rod dystrophy | 0.72210835127064 | |||
| Q9BWF2 | TRAIP | E3 ubiquitin-protein ligase TRAIP | Tier 1.5 | 0.595 | 1 | A2_pm_peripheral | 1 | 74.94 | 0 | 0 | 0 | 0 | 0 | Seckel syndrome 9 | 0.683878095944948 | |||
| Q4KMQ1 | TPRN | Taperin | Tier 1.5 | 0.595 | 1 | A2_pm_peripheral | 1 | 54.44 | 0 | 0 | 0 | 0 | 0 | hearing loss, autosomal recessive | 0.6844134134291492 | |||
| Q8IUC6 | TICAM1 | TIR domain-containing adapter molecule 1 | Tier 1.5 | 0.581 | 1 | A2_pm_peripheral | 8 | 62.78 | 1 | 0 | 0 | 0 | 0 | Herpetic encephalitis | 0.6364986386236531 | |||
| P50607 | TUB | Tubby protein homolog | Tier 1.5 | 0.579 | 1 | A2_pm_peripheral | 1 | 69.12 | 0 | 0 | 0 | 0 | 0 | retinitis pigmentosa | 0.631297844631827 | |||
| Q2Q1W2 | TRIM71 | E3 ubiquitin-protein ligase TRIM71 | Tier 1.5 | 0.578 | 1 | A2_pm_peripheral | 2 | 79.12 | 0 | 0 | 1 | 2 | 31732746 | 0 | hydrocephalus, congenital communicating, 1 | 0.6276048232841862 | ||
| P56597 | NME5 | Nucleoside diphosphate kinase 5 | Tier 1.5 | 0.563 | 1 | A2_pm_peripheral | 1 | 90.06 | 1 | 0 | 0 | 0 | 0 | ciliary dyskinesia, primary, 48, without situs inversus | 0.5766985649142533 | |||
| Q8WWN9 | IPCEF1 | Interactor protein for cytohesin exchange factors 1 | Tier 1.5 | 0.547 | 1 | A2_pm_peripheral | 1 | 64.06 | 0 | 0 | 0 | 0 | 0 | response to tramadol | 0.5225136314922196 | |||
| Q8N8R7 | ARL14EP | ARL14 effector protein | Tier 1.5 | 0.546 | 1 | A2_pm_peripheral | 1 | 80.69 | 0 | 0 | 0 | 0 | 0 | endometriosis | 0.5215169504121038 | |||
| Q5UIP0 | RIF1 | Telomere-associated protein RIF1 | Tier 1.5 | 0.541 | 1 | A2_pm_peripheral | 1 | 53.78 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5038900373620092 | |||
| Q9GZN1 | ACTR6 | Actin-related protein 6 | Tier 1.5 | 0.533 | 1 | A2_pm_peripheral | 9 | 94.31 | 1 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.4758409073452339 | |||
| Q9UKI9 | POU2F3 | POU domain, class 2, transcription factor 3 | Tier 1.5 | 0.523 | 1 | A2_pm_peripheral | 3 | 59.34 | 0 | 0 | 0 | 0 | 0 | erythematosquamous dermatosis | 0.44361239146188985 | |||
| O75747 | PIK3C2G | Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma | Tier 1.5 | 0.523 | 1 | A2_pm_peripheral | 1 | 73.62 | 0 | 0 | 0 | 0 | 0 | mathematical ability | 0.4448369190532247 | |||
| Q9Y2I2 | NTNG1 | Netrin-G1 | Tier 1.5 | 0.522 | 1 | A2_pm_peripheral | 1 | 83.62 | 0 | 0 | 0 | 0 | 0 | obesity | 0.438954995963001 | |||
| O95149 | SNUPN | Snurportin-1 | Tier 1.5 | 0.518 | 1 | A2_pm_peripheral | 11 | 82.81 | 0 | 0 | 0 | 0 | 0 | muscular dystrophy, limb-girdle, autosomal recessive 29 | 0.42732670697918645 | |||
| Q5VTH2 | CFAP126 | Protein Flattop | Tier 1.5 | 0.51 | 1 | A2_pm_peripheral | 2 | 72.62 | 1 | 0 | 0 | 0 | 0 | hereditary pheochromocytoma-paraganglioma | 0.4009925718465981 | |||
| Q9Y2K6 | USP20 | Ubiquitin carboxyl-terminal hydrolase 20 | Tier 1.5 | 0.509 | 1 | A2_pm_peripheral | 1 | 72.31 | 0 | 0 | 1 | 1 | 30863411 | 0 | connective tissue neoplasm | 0.3981371748391643 | ||
| O95049 | TJP3 | Tight junction protein ZO-3 | Tier 1.5 | 0.508 | 1 | A2_pm_peripheral | 1 | 66.81 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.3927046238887248 | |||
| Q6ZUJ8 | PIK3AP1 | Phosphoinositide 3-kinase adapter protein 1 | Tier 1.5 | 0.507 | 1 | A2_pm_peripheral | 2 | 64.94 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.39164159393726217 | |||
| Q14CW9 | ATXN7L3 | Ataxin-7-like protein 3 | Tier 1.5 | 0.501 | 1 | A2_pm_peripheral | 1 | 65.44 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.3695798546847018 | |||
| Q9HCH5 | SYTL2 | Synaptotagmin-like protein 2 | Tier 1.5 | 0.501 | 1 | A2_pm_peripheral | 9 | 57.72 | 0 | 0 | 0 | 0 | 0 | obstructive sleep apnea | 0.36964540101000476 | |||
| Q9UQK1 | PPP1R3C | Protein phosphatase 1 regulatory subunit 3C | Tier 1.5 | 0.501 | 1 | A2_pm_peripheral | 4 | 67.62 | 0 | 0 | 0 | 0 | 0 | disorder of glycogen metabolism | 0.3695798546847018 | |||
| O75182 | SIN3B | Paired amphipathic helix protein Sin3b | Tier 1.5 | 0.501 | 1 | A2_pm_peripheral | 4 | 68.0 | 1 | 0 | 1 | 2 | 16914451 | 0 | syndromic intellectual disability | 0.37050380432141355 | ||
| P58340 | MLF1 | Myeloid leukemia factor 1 | Tier 1.5 | 0.501 | 1 | A2_pm_peripheral | 3 | 67.0 | 0 | 0 | 0 | 0 | 0 | lymphoid neoplasm | 0.3695798546847018 | |||
| P32298 | GRK4 | G protein-coupled receptor kinase 4 | Tier 1.5 | 0.49 | 1 | A2_pm_peripheral | 1 | 88.69 | 0 | 0 | 1 | 2 | 31555351 | 0 | Nausea and vomiting | 0.33267400228074584 | ||
| P10632 | CYP2C8 | Cytochrome P450 2C8 | Tier 1.5 | 0.486 | 1 | A2_pm_peripheral | 5 | 93.06 | 0 | 0 | 0 | 0 | 0 | Abnormality of the skeletal system | 0.3211518152079769 | |||
| Q9ULJ8 | PPP1R9A | Neurabin-1 | Tier 1.5 | 0.476 | 1 | A2_pm_peripheral | 2 | 59.62 | 0 | 0 | 0 | 0 | 0 | myeloid leukemia | 0.28568410491371843 | |||
| P57771 | RGS8 | Regulator of G-protein signaling 8 | Tier 1.5 | 0.474 | 1 | A2_pm_peripheral | 3 | 81.25 | 0 | 0 | 0 | 0 | 0 | Hematemesis | 0.28069850888564046 | |||
| O75604 | USP2 | Ubiquitin carboxyl-terminal hydrolase 2 | Tier 1.5 | 0.469 | 1 | A2_pm_peripheral | 8 | 68.12 | 0 | 0 | 0 | 0 | 0 | refractive error | 0.26457439923389525 | |||
| P55089 | UCN | Urocortin | Tier 1.5 | 0.469 | 1 | A2_pm_peripheral | 6 | 68.25 | 1 | 0 | 1 | 3 | 30221506, 26488412, 23248006 | 0 | neurodegenerative disease | 0.26311734927710556 | ||
| Q8N448 | LNX2 | Ligand of Numb protein X 2 | Tier 1.5 | 0.448 | 1 | A2_pm_peripheral | 7 | 74.62 | 0 | 0 | 0 | 0 | 0 | exostosis | 0.19343380355753698 | |||
| P19957 | PI3 | Elafin | Tier 1.5 | 0.446 | 1 | A2_pm_peripheral | 3 | 72.25 | 0 | 0 | 1 | 3 | 37351609, 36517803, 30087279 | 0 | Abruptio Placentae | 0.18626794135552627 | ||
| Q9UFD9 | RIMBP3 | RIMS-binding protein 3A | Tier 1.5 | 0.421 | 1 | A2_pm_peripheral | 1 | 57.53 | 0 | 0 | 0 | 0 | 0 | azoospermia | 0.10375257721432407 | |||
| Q5T1H1 | EYS | Protein eyes shut homolog | Tier 1.5 | 0.39 | 0 | A2_pm_peripheral | 0 | 56.53 | 0 | 0 | 0 | 0 | 0 | retinitis pigmentosa | 0.8167306715305448 | |||
| Q86UC2 | RSPH3 | Radial spoke head protein 3 homolog | Tier 1.5 | 0.39 | 1 | A2_pm_peripheral | 1 | 64.62 | 1 | 0 | 0 | 0 | 0 | |||||
| P98174 | FGD1 | FYVE, RhoGEF and PH domain-containing protein 1 | Tier 1.5 | 0.389 | 0 | A2_pm_peripheral | 0 | 64.81 | 0 | 0 | 0 | 0 | 0 | Aarskog-Scott syndrome, X-linked | 0.8139881587444686 | |||
| Q9H4F8 | SMOC1 | SPARC-related modular calcium-binding protein 1 | Tier 1.5 | 0.388 | 0 | A2_pm_peripheral | 0 | 73.31 | 0 | 0 | 1 | 1 | 36333824 | 0 | microphthalmia with limb anomalies | 0.8103774498041117 | ||
| Q92539 | LPIN2 | Phosphatidate phosphatase LPIN2 | Tier 1.5 | 0.385 | 0 | A2_pm_peripheral | 0 | 60.5 | 0 | 0 | 0 | 0 | 0 | Majeed syndrome | 0.8006214215390607 | |||
| O75061 | DNAJC6 | Auxilin | Tier 1.5 | 0.38 | 0 | A2_pm_peripheral | 0 | 62.88 | 0 | 0 | 0 | 0 | 0 | Young adult-onset Parkinsonism | 0.784924972265951 | |||
| Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | Tier 1.5 | 0.374 | 0 | A2_pm_peripheral | 0 | 95.81 | 0 | 0 | 1 | 10 | 40271962, 35780537, 35539643, 26547498, 24994506 | 0 | Alpha-methylacyl-CoA racemase deficiency | 0.762086344446303 | ||
| Q5VTD9 | GFI1B | Zinc finger protein Gfi-1b | Tier 1.5 | 0.365 | 0 | A2_pm_peripheral | 0 | 63.81 | 0 | 0 | 0 | 0 | 0 | platelet-type bleeding disorder 17 | 0.7329750493288353 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;